Vireo Growth (VREOF) Goodwill & Intangibles (2020 - 2026)
Vireo Growth (VREOF) posted Goodwill & Intangibles of $202.5 million for Q1 2026, up 0.9% sequentially from $200.7 million in Q4 2025, and up 2531.74% YoY from $7.7 million in Q1 2025.
Vireo Growth (VREOF) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Vireo Growth has reported Goodwill & Intangibles for 7 years, with the latest figure at $202.5 million in Q1 2026.
- Quarterly Goodwill & Intangibles rose 2531.74% year-over-year to $202.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $202.5 million (up 2531.74% YoY) and the FY2025 annual result came in at $200.7 million, up 2440.51% from the prior year.
- Goodwill & Intangibles improved to $202.5 million in Q1 2026 per VREOF's latest filing, from $200.7 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $202.5 million in Q1 2026 and troughed at $7.7 million in Q1 2025.
- A 5-year average of $50.1 million and a median of $8.9 million in 2023 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2022 and 2026: Goodwill & Intangibles sank 30.25% in 2022, then surged 2531.74% in 2026.
- Over 5 years, Goodwill & Intangibles stood at $9.0 million in 2022, then slipped by 0.65% to $8.9 million in 2023, then dropped by 11.26% to $7.9 million in 2024, then jumped by 2440.51% to $200.7 million in 2025, then gained by 0.9% to $202.5 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $202.5 million, $200.7 million, and $180.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Vireo Growth | 491.44 Mn | 349.14 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202.50 Mn |
| Dec 31, 2025 | 200.70 Mn |
| Sep 30, 2025 | 180.47 Mn |
| Jun 30, 2025 | 151.85 Mn |
| Mar 31, 2025 | 7.69 Mn |
| Dec 31, 2024 | 7.90 Mn |
| Sep 30, 2024 | 8.10 Mn |
| Jun 30, 2024 | 8.31 Mn |
| Mar 31, 2024 | 8.51 Mn |
| Dec 31, 2023 | 8.90 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | 8.05 Mn |
| Mar 31, 2023 | 8.80 Mn |
| Dec 31, 2022 | 8.96 Mn |
| Sep 30, 2022 | 11.89 Mn |
| Jun 30, 2022 | 9.96 Mn |
| Mar 31, 2022 | 10.13 Mn |
| Dec 31, 2021 | 10.37 Mn |
| Sep 30, 2021 | 5.61 Mn |
| Jun 30, 2021 | 6.32 Mn |